Skip to content

Research on comprehensive thrapy with traditional Chinese medicine for acute attack of bronchial asthmas

Research on comprehensive thrapy with traditional Chinese medicine for acute attack of bronchial asthmas

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000464
Enrollment
Unknown
Registered
2009-07-22
Start date
2008-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthmas

Interventions

B:Applying with Chinese drugs at the acupoint (Fei Yu, Ding Chuan, Shan Zhong, Tian Tu) bid 10 days
Granules of Chinese medicine formula as Group C
add Ventolin Aerosol if needed.
A:Theophylline Sustainderelease bid 10 dyas
Flixotide Aerosol 125µg/inhale bid 10 dyas
C:Hot wheezing: Qinlong Zhixiao Decoction Granules bid 10 days
cold wheezing: Suma Wenfei Pingxiao Decoction Granules bid 10 days
windy wheezing: Masu Zhixiao Decoction Granules bid 10 days
add Ventolin Aerosol if needed

Sponsors

Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Acute attack of bronchial asthmas according to the diagnostic standard of bronchial asthmas; 2. Severity of the disease: mild to moderate (intermittent and mild persistent); 3. Meeting with the diagnostic standard for TCM syndrome differentiation; 4. Age 18-65 years old, male or female; 5. With the informed consent signed.

Exclusion criteria

Exclusion criteria: 1. patients with hormone-dependent asthma; 2. Complicated with bronchiectasia, tuberculosis, pulmonary fibrosis and other primary pulmonary disease; 3. Complicated with severe primary disease of heart, liver, kidney and hemotopoiesis; 4. Complicated with psychiatric disease; 5. Pregnant and lactating women or allergic constitution; 6. Poor appliance and barrier in conversation; 7. Participated in blood donation and other clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Times of choking during sleep;TCM manifestation scores;Times of ß2 agonists used;Plumonary functio;

Secondary

MeasureTime frame
Eosinophil count;Tongue coating;Pulse manifestation;Interleukin-8;Eosinophil cationic protein;Tongue tincture;

Countries

China

Contacts

Public ContactZengtao Sun
szta20042@eyou.com+86 022 60335300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026